GlobeNewswire
Dublin, March 01, 2021 (GLOBE NEWSWIRE) -- The "Sepsis Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product; By Technology; By Pathogen; By Testing Type; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global sepsis diagnostics market size is predicted to reach USD 1.03 billion by 2027The key factors responsible for the market growth include innovations in biomarker-based sepsis diagnosis; growing medical attention towards ill effects of sepsis and its economic burden; and the development of technologically advanced rapid PoC diagnosis systems. Moreover, the favorable reimburse scenario in developed economies and burgeoning healthcare infrastructure in low and middle-income countries is expected to propel market growth.The market is fragmented based on product, technology, pathogen, type, and region. In terms of product, the market is segmented into instruments, blood culture media, assay kits and reagents, and software. Based on technology, the market is further bifurcated into microbiology, molecular diagnostics, biomarkers, immunoassays, and flow cytometry. Based on pathogen, the market is classified as bacterial sepsis, fungal sepsis, and others. The type segment is further divided into laboratory testing, and PoC testing.Segment Highlights The blood culture media segment accounted for the largest revenue share of the global market as it is used in maximum cases for diagnosis. However, the kits & reagents market segment is expected to witness fastest growth over the forecast period.Microbiology technology segment is expected to account for the largest revenue share by the end of 2027 as the technology aids in quantitative identification and detection of microorganisms through culture media tests.Laboratory testing segment is expected to witness significant growth over the forecast period on account of the increasing number of blood cultures conducted in laboratories across the globe.North America region is dominating the market, holding a significant market share throughout the forecast period. The presence of major players in the region, industry-academia collaboration, and intellectual capability of the U.S. are major factors responsible for the region's growth. List of Key Players bioMerieuxBecton DickinsonDanaher CorporationAbbott LaboratoriesThermo Fisher ScientificEKF DiagnosticsRoche Diagnostics Key Topics Covered: 1. Introduction2. Executive Summary3. Research Methodology4. Sepsis Diagnostics Market Insights4.1. Sepsis Diagnostics - Industry snapshot4.2. Sepsis Diagnostics Market Dynamics4.2.1. Drivers and Opportunities4.2.1.1. Innovations in biomarker based sepsis diagnosis4.2.1.2. Point of care diagnostic tools4.2.2. Restraints and Challenges4.2.2.1. High procurement cost of reagents4.3. Porter's Five Forces Analysis4.4. PESTLE Analysis4.5. Sepsis Diagnostics Market Industry trends5. Sepsis Diagnostics Market Assessment by Product5.1. Key Findings5.2. Introduction5.2.1. Global Sepsis Diagnostics Market, By Product, 2016-2027 (USD Million)5.3. Instruments5.4. Blood Culture Media5.5. Assay Kits and Reagents5.6. Software6. Global Sepsis Diagnostics Market, by Technology6.1. Key Findings6.2. Introduction6.2.1. Global Sepsis Diagnostics Market, By Technology, 2016-2027 (USD Million)6.3. Microbiology6.4. Molecular Diagnostics6.5. Biomarkers6.6. Immunoassays6.7. Flow Cytometry7. Global Sepsis Diagnostics Market, by Pathogen7.1. Key Findings7.2. Introduction7.2.1. Global Sepsis Diagnostics Market, By Pathogen, 2016-2027 (USD Million)7.3. Bacterial Sepsis7.3.2. Gram-Positive Bacteria7.3.3. Gram-Negative Bacteria7.4. Fungal Sepsis8. Sepsis Diagnostics Market Assessment by Testing Type8.1. Key Findings8.2. Introduction8.2.1. Global Sepsis Diagnostics Market, By Testing Type, 2016-2027 (USD Million)8.3. Laboratory Testing8.4. PoC Testing9. Sepsis Diagnostics Market Assessment by Geography9.1. Key findings9.2. Introduction9.2.1. Sepsis Diagnostics Market Assessment, By Geography, 2016- 2027 (USD Million) bioMerieuxAxis-Shield DiagnosticsBecton DickinsonDanaher CorporationAbbott LaboratoriesLuminexThermo Fisher ScientificEKF DiagnosticsImmunexpressBrukerRoche DiagnosticsT2 BiosystemsResponse BiomedicalCytoSorbents For more information about this report visit https://www.researchandmarkets.com/r/agcv8e CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900